The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

HAGERSTRAND Daniel ODER Blaz CORTESE Diego QU Ying BINZER-PANCHAL Amrei OSTERHOLM Cecilia SANTOS Teresa Del Peso RABBANI Leily ASL Hassan Foroughi SKAFTASON Aron LJUNGSTROM Viktor LUNDHOLM August KOUTROUMANI Maria HAIDER Zahra JYLHA Cecilia MOLLSTEDT John MANSOURI Larry PLEVOVÁ Karla AGATHANGELIDIS Andreas SCARFO Lydia ARMAND Marine MUGGEN Alice F KAY Neil E SHANAFELT Tait ROSSI Davide ORRE Lukas M POSPÍŠILOVÁ Šárka BARYLYUK Konstantin DAVI Frederic VESTERLUND Mattias LANGERAK Anton W LEHTIO Janne GHIA Paolo STAMATOPOULOS Kostas SUTTON Lesley-Ann ROSENQUIST Richard

Year of publication 2024
Type Article in Periodical
Magazine / Source Leukemia
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.nature.com/articles/s41375-024-02379-4
Doi http://dx.doi.org/10.1038/s41375-024-02379-4
Attached files
Description SF3B1 mutations are recurrent in chronic lymphocytic leukemia (CLL), particularly enriched in clinically aggressive stereotyped subset #2. To investigate their impact, we conducted RNA-sequencing of 18 SF3B1(MUT) and 17 SF3B1(WT) subset #2 cases and identified 80 significant alternative splicing events (ASEs). Notable ASEs concerned exon inclusion in the non-canonical BAF (ncBAF) chromatin remodeling complex subunit, BRD9, and splice variants in eight additional ncBAF complex interactors. Long-read RNA-sequencing confirmed the presence of splice variants, and extended analysis of 139 CLL cases corroborated their association with SF3B1 mutations. Overexpression of SF3B1(K700E) induced exon inclusion in BRD9, resulting in a novel splice isoform with an alternative C-terminus. Protein interactome analysis of the BRD9 splice isoform revealed augmented ncBAF complex interaction, while exhibiting decreased binding of auxiliary proteins, including SPEN, BRCA2, and CHD9. Additionally, integrative multi-omics analysis identified a ncBAF complex-bound gene quartet on chromosome 1 with higher expression levels and more accessible chromatin in SF3B1(MUT) CLL. Finally, Cancer Dependency Map analysis and BRD9 inhibition displayed BRD9 dependency and sensitivity in cell lines and primary CLL cells. In conclusion, spliceosome dysregulation caused by SF3B1 mutations leads to multiple ASEs and an altered ncBAF complex interactome, highlighting a novel pathobiological mechanism in SF3B1(MUT) CLL.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.